OVERVIEW
The market for injectable drug delivery is expected to rise at 10.12% CAGR over the 2020-2025 forecast period. The key factors responsible for this market’s growth are increased use of biologics, increased incidence of chronic diseases, increased needlestick injuries, and the advantages of injections (convenience, ease of use, and reduced pain).
TABLE OF CONTENT
1 Global Injectable Drug Delivery Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Injectable Drug Delivery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Injectable Drug Delivery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Injectable Drug Delivery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Injectable Drug Delivery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Injectable Drug Delivery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Injectable Drug Delivery Market – By Type (Market Size – & million/billion)
8.1 Devices
8.2 Formulations
9 Global Injectable Drug Delivery Market – By Formulation Packaging
9.1 Ampules
9.2 Vials
9.3 Cartridges
9.4 Bottles
10 Global Injectable Drug Delivery Market – By Therapeutic Application
10.1 Auto-immune diseases
10.2 Hormonal Disorders
10.3 Orphan Diseases
10.4 Oncology
10.5 Other
11 Global Injectable Drug Delivery Market – By Distribution Channel
11.1 Hospitals
11.2 Retail Pharmacy Stores
12 Global Injectable Drug Delivery Market – By End-User
12.1 Hospitals & Clinics
12.2 Home Care Settings
12.3 Other
13 Global Injectable Drug Delivery Market – By Geography (Market Size – & million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Injectable Drug Delivery Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global Injectable Drug Delivery Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Baxter International, Inc.
15.3 Becton, Dickinson and Company
15.4 Gerresheimer Ag
15.5 Pfizer, Inc.
15.6 Schott Ag
15.7 Eli Lilly and Company
15.8 Sandoz (A Division of Novartis Ag)
15.9 Terumo Corporation
15.10 Teva Pharmaceutical Industries Ltd.
15.11 Company 10
15.12 Company 11 & more
16 Global Injectable Drug Delivery Market – Appendix
16.1 Sources
16.2 Abbreviations